Kromek Group PLC New Nuclear Security order from US federal entity (6866M)
May 25 2022 - 3:30AM
UK Regulatory
TIDMKMK
RNS Number : 6866M
Kromek Group PLC
25 May 2022
25 May 2022
Kromek Group plc
("Kromek" or the "Group")
Kromek receives new Nuclear Security order from US federal
entity
Repeat order received for D3S-ID 'dirty bomb' detector
Kromek (AIM: KMK), a leading developer of radiation and
bio-detection technology solutions for the advanced imaging and
CBRN detection segments, announces that it has received an order
from a US federal entity for the Group's D3S-ID wearable nuclear
radiation detector. The order is worth $695,000 and is to be
delivered in the coming months. This is a repeat order for the
D3S-ID from this customer, following the award of a $1.6m two-year
contract in September 2021.
The D3S-ID is designed to enable first responders, armed forces,
border security and other CBRN experts to detect radiological
threats such as dirty bombs , radioactive contamination and
smuggling of radioactive substances . It is a wearable gamma
neutron RIID (radioisotope identification device) that the Group
believes is one of the fastest and most accurate isotope
identification devices in its class on the market. Kromek's D3S
platform - comprising the Group's range of D3S products - is widely
deployed as a networked solution to protect cities, buildings, or
critical infrastructure.
Dr Arnab Basu, CEO of Kromek, said: "We're pleased to have
received this latest order for our D3S-ID nuclear radiation
detector that provides security authorities with an early warning
system for potential threats. Being awarded a repeat order for this
product from this important customer is a great endorsement. With
the volatility of the current geopolitical environment, we are
receiving heightened demand for our CBRN solutions, from new and
existing customers, as governments become increasingly aware of the
need to enhance their real-time threat monitoring. We believe that
our solutions are best placed to provide them with this capability
and, accordingly, we expect to receive further orders for our
nuclear security products in the near term."
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO
Paul Farquhar, CFO +44 (0)1740 626 060
finnCap Ltd (Nominated Adviser and Broker)
Geoff Nash/Kate Bannatyne/George Dollemore
- Corporate Finance +44 (0)20 7220 0500
Tim Redfern/Charlotte Sutcliffe - ECM
Luther Pendragon (Financial PR)
Harry Chathli/Claire Norbury +44 (0)20 7618 9100
About Kromek Group plc
Kromek Group plc is a leading developer of radiation detection
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments. Headquartered in County Durham, UK, Kromek
has manufacturing operations in the UK and US, delivering on the
vision of enhancing the quality of life through innovative
detection technology solutions.
The advanced imaging segment comprises the medical (including CT
and SPECT), security and industrial markets. Kromek provides its
OEM customers with detector components, based on its core cadmium
zinc telluride (CZT) platform, to enable better detection of
diseases such as cancer and Alzheimer's, contamination in
industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation
detection solutions to the global homeland defence and security
market. Kromek's compact, handheld, high-performance radiation
detectors, based on advanced scintillation technology, are
primarily used to protect critical infrastructure and urban
environments from the threat of 'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN
detection segment. These consist of fully automated and autonomous
systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange,
under the trading symbol 'KMK'.
Further information is available at www.kromek.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFZLLLLELZBBE
(END) Dow Jones Newswires
May 25, 2022 03:30 ET (07:30 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kromek (LSE:KMK)
Historical Stock Chart
From Jul 2023 to Jul 2024